Pancreatic Cancer Research

ResearcherKoç UniversityActive in the last 2 years

Uğur Selek

Matched on ORCID iD 0000-0001-8087-3140; OpenAlex author ID A5014100095.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
3 (first author 0, last author 1)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
4
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 3

  1. High Systemic Immune-Inflammation Index Values Before Treatment Predict Poor Pancreatic Cancer Outcomes After Definitive Chemoradiotherapy. Co-author DOI 10.1177/11795549241298552↗
  2. High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients. Co-author DOI 10.2147/tcrm.s359553↗
  3. Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treat… Last author DOI 10.1186/1748-717x-7-37↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Erkan Topkan · 3 shared papers, 2012–2024
  2. Berrin Pehlivan · 2 shared papers, 2022–2024
  3. Ahmet Küçük · 2 shared papers, 2022–2024
  4. Cem Parlak · 1 shared paper, 2012

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.